WallStreetZenWallStreetZen

NASDAQ: CNTN
Canton Strategic Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CNTN stock forecasts and price targets.

Forecast return on equity

Is CNTN forecast to generate an efficient return?

Company
-40.65%
Industry
52.83%
Market
351.12%
CNTN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CNTN forecast to generate an efficient return on assets?

Company
-32.5%
Industry
12.1%
CNTN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CNTN earnings per share forecast

What is CNTN's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.07

CNTN revenue forecast

What is CNTN's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0

CNTN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CNTN$4.51N/AN/A
PRQR$1.47$4.00+172.11%Strong Buy
TLSA$1.40N/AN/A
ELTX$8.86N/AN/A
FATE$1.40$6.00+328.57%Buy
View Top Biotech Stocks

Canton Strategic Holdings Stock Forecast FAQ

What is CNTN's earnings growth forecast for 2026-2026?

(NASDAQ: CNTN) Canton Strategic Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Canton Strategic Holdings's earnings in 2026 is -$10,319,245.

In 2026, CNTN is forecast to generate -$2,502,200 in earnings, with the lowest earnings forecast at -$2,404,074 and the highest earnings forecast at -$2,575,794.

If you're new to stock investing, here's how to buy Canton Strategic Holdings stock.

What is CNTN's revenue growth forecast for 2026-2026?

(NASDAQ: CNTN) Canton Strategic Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Canton Strategic Holdings's revenue in 2026 is $0.

In 2026, CNTN is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is CNTN's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: CNTN) forecast ROA is -32.5%, which is lower than the forecast US Biotechnology industry average of 12.1%.

What is CNTN's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: CNTN) Canton Strategic Holdings's current Earnings Per Share (EPS) is -$3.99. In 2026, CNTN's EPS is forecast to hit -$0.07 (min: -$0.07, max: -$0.07).

What is CNTN's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: CNTN) forecast ROE is -40.65%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.